Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial.
- 2016-07
- RCT · n = 39
- Applied Physiology, Nutrition, and Metabolism 41(7)
- D. Michaličková
- R. Minić
- N. Dikić
- M. Andjelkovic
- Marija Kostic-Vucicevic
- Tamara Stojmenovic
- Ivan Nikolić
- B. Djordjevic
- PubMed: 27363733
- DOI: 10.1139/apnm-2015-0541
- High evidence
Group effect for CD4+/CD8+ ratio was significant (F[1,37] = 6.99, p = 0.020, η(2) = 0.350); this difference was not significant at baseline, but was evident after 14 weeks (p = 0.02).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes